Factors related to the development of high antibody titres against SARS-CoV-2 in convalescent plasma donors from the ConPlas-19 trial.

Irene Romera MartínezCristina Avendaño-SoláCarolina Villegas Da RosAlba Bosch LlobetJosé Antonio García ErceMaría Isabel González FraileLuisa Guerra DomínguezIsabel Vicuña AndrésJavier Anguita VelascoVictoria Paz González RodríguezEnric ContrerasSabin Urcelay UrangaÁngel Luis Pajares HerraizTeresa Jimenez-MarcoAna María Ojea PérezJosé Luis Arroyo RodríguezMayte Pérez-OlmedaAntonio Ramos-MartínezAna Velasco-IglesiasJosé Luis Bueno CabreraRafael F Duarte

Published in: Vox sanguinis (2023)

SARS-CoV-2 CP candidate donors' age, duration of COVID-19 symptoms and time from infection to donation associate with the collection of CP with high antibody levels. Beyond COVID-19, these data are relevant to inform decisions to optimize the CP donor selection process in potential future outbreaks.

Keyphrases

sars cov
respiratory syndrome coronavirus
coronavirus disease
clinical trial
study protocol
kidney transplantation
electronic health record
randomized controlled trial
machine learning
risk assessment
physical activity
deep learning
infectious diseases